SEC Comment Letter for Traws Pharma, Inc. (TRAW) (CIK 0001130598) (TRAW) — Apr 11, 2019
Traws Pharma, Inc. (TRAW) (CIK 0001130598)
Date: April 11, 2019 · CIK: 0001130598 · Accession: 0000000000-19-007001
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-230744
Letter
April 11, 2019 Steven M. Fruchtman, M.D. Chief Executive Officer Onconova Therapeutics, Inc. 375 Pheasant Run Newtown, PA 18940 Re:Onconova Therapeutics, Inc. Registration Statement on Form S-3 Filed April 5, 2019 File No. 333-230744 Dear Dr. Fruchtman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tonya K. Aldave at (202) 551-3601 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Joanne R. Soslow, Esq.
Show Raw Text
April 11, 2019
Steven M. Fruchtman, M.D.
Chief Executive Officer
Onconova Therapeutics, Inc.
375 Pheasant Run
Newtown, PA 18940
Re:Onconova Therapeutics, Inc.
Registration Statement on Form S-3
Filed April 5, 2019
File No. 333-230744
Dear Dr. Fruchtman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tonya K. Aldave at (202) 551-3601 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Joanne R. Soslow, Esq.